Client Server Image Analysis Tools for Clinical Trials
About the Research Project
Program
Award Type
Standard
Award Amount
$37,500
Active Dates
April 01, 2000 - March 31, 2001
Grant ID
M2000031
Summary
Evaluating the success of treatments for AMD is complicated by the current methods used for measuring clinical improvement. Doctors now perform a visual inspection of the fundus (the inside surface of the back of the eyeball) and attempt to measure changes over time. For the best results, trained experts must make these examinations at a formal “reading center.” Even in this setting, there are problems associated with human grading systems. In addition, many of the clinical trials for the treatment of AMD that are ongoing around the world are small in size and do not have access to a formal reading center. Dr. Berger believes that both large and small trials could benefit from internet-based access to a computerized method of performing efficient, accurate, and objective measurements. He has dedicated himself to developing a computerized reading center to permit a computer-assisted analysis that doctors and scientists can access on a worldwide basis. Such a system would allow for larger clinical trials because of increased efficiency and would enhance the usefulness of smaller trials because of increased accuracy. This study represents a continuation of last year’s study by the same name.
Grants
Related Grants
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD